VPHIF (Valeo Pharma) EPS (Basic): $-0.25 (TTM As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma EPS (Basic)?

Valeo Pharma VPHIF -99.00% 12 EPS (Basic) is $-0.25 as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Valeo Pharma's basic earnings per share (Basic EPS) for the three months ended in Jul. 2024 was $-0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jul. 2024 was $-0.25.

Valeo Pharma's EPS (Diluted) for the three months ended in Jul. 2024 was $-0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jul. 2024 was $-0.25.

Valeo Pharma's EPS without NRI for the three months ended in Jul. 2024 was $-0.05. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jul. 2024 was -0.24.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Valeo Pharma  (OTCPK:VPHIF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Valeo Pharma EPS (Basic) Related Terms

Valeo Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma EPS (Basic) Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EPS (Basic)
Get a 7-Day Free Trial -0.05 -0.06 -0.16 -0.23 -0.23

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.07 -0.06 -0.06 -0.06
VPHIF
12GF Score
Valeo Pharma Inc VPHIF
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Valeo Pharma's Basic EPS for the fiscal year that ended in Oct. 2023 is calculated as

Basic EPS (A: Oct. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-20.28-0)/86.117
=-0.24

Valeo Pharma's Basic EPS for the quarter that ended in Jul. 2024 is calculated as

Basic EPS (Q: Jul. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5.973-0)/98.675
=-0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.25 mean?
Valeo Pharma (VPHIF) has a EPS (Basic) of $-0.25 as of Jul. 2024. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's EPS (Basic) too high?
Valeo Pharma's current EPS (Basic) is $-0.25. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's EPS (Basic) compare to ZTS?
Valeo Pharma's EPS (Basic) of $-0.25 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Valeo Pharma and its competitors. Valeo Pharma's current EPS (Basic) is $-0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current EPS (Basic) of $-0.25. The current EPS (Basic) is $-0.25. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current EPS (Basic) is $-0.25 as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price